Compound Catalogue
273 of ours + 1 from pep-pedia. Every compound in our research wiki cross-referenced against pep-pedia's structured peptide database. Filter by coverage to find what we have versus what's still on the to-research list.
Total
274
273 ours + 1 theirs-only
Have both
74
Deepest data — overlap with pep-pedia
Ours only
199
Broader nootropic universe
Theirs only
1
Peptides not yet researched
Coverage
274 shown
Cerebrolysin
Both
Neuropeptide Preparation | Neurological Recovery
PRIMARY-PICK P-P Well Researched peptide-injectable
+ pep-pedia data merged →
BPC-157
Both
Body Protection Compound-157 | Pentadecapeptide
STRONG-CANDIDATE P-P Extensively Studied peptide-injectable
+ pep-pedia data merged →
Bromantane
Both
Adamantane Actoprotector | Dopamine Synthesis Enhancer
STRONG-CANDIDATE P-P Well Researched pill-oral-pharmaceutical
+ pep-pedia data merged →
N-Acetyl Semax Amidate
Both
Enhanced Nootropic Peptide | Cognitive Enhancement & Neuroprotection
STRONG-CANDIDATE P-P Well Researched peptide-intranasal
+ pep-pedia data merged →
Selank
Both
Synthetic Tuftsin Analog | Anxiolytic & Nootropic Peptide
STRONG-CANDIDATE P-P Well Researched peptide-intranasal
+ pep-pedia data merged →
Semax
Both
Synthetic ACTH Analog | Cognitive Enhancement Peptide
STRONG-CANDIDATE P-P Well Researched peptide-intranasal
+ pep-pedia data merged →
TB-500
Both
Ac-LKKTETQ | Synthetic Fragment (17-23) of Thymosin Beta-4
STRONG-CANDIDATE P-P Well Researched peptide-injectable
+ pep-pedia data merged →
Acetyl-L-Carnitine
Both
Amino Acid Derivative | Energy & Fat Metabolism
OPTIONAL-ADD P-P Well Researched capsule-supplement
+ pep-pedia data merged →
GHK-Cu (Copper Tripeptide-1)
Both
Copper Peptide | Skin Regeneration & Anti-Aging Compound
OPTIONAL-ADD P-P Well Researched topical
+ pep-pedia data merged →
GLOW Peptide Stack
Both
Peptide stack (3-peptide regenerative blend; KLOW-subset)
OPTIONAL-ADD P-P Limited Research
+ pep-pedia data merged →
KPV (Lys-Pro-Val tripeptide)
Both
Anti-Inflammatory Tripeptide | Alpha-MSH Fragment
OPTIONAL-ADD P-P Emerging Research topical
+ pep-pedia data merged →
MOTS-c
Both
Mitochondrial Open Reading Frame of the 12S rRNA-c
OPTIONAL-ADD P-P Extensively Studied peptide-injectable
+ pep-pedia data merged →
NAD+ (covering NMN, NR, NAD+ Injectable)
Both
Essential Cellular Coenzyme | Anti-Aging Therapy
OPTIONAL-ADD P-P Extensively Studied capsule-supplement
+ pep-pedia data merged →
SS-31 (Elamipretide)
Both
Mitochondrial-Targeted Peptide | Cardiolipin Protector
OPTIONAL-ADD P-P FDA Approved peptide-injectable
+ pep-pedia data merged →
Wolverine Stack (BPC-157 + TB-500)
Both
Peptide stack
OPTIONAL-ADD P-P Well Researched
+ pep-pedia data merged →
5-Amino-1MQ
Both
NNMT inhibitor (nicotinamide N-methyltransferase inhibitor) — small-molecule oral; methylation
WATCH-LIST
+ pep-pedia data merged →
Adalank
Both
Russian-peptide
WATCH-LIST P-P Emerging Research
+ pep-pedia data merged →
AHK-Cu (Copper Tripeptide-3)
Both
Synthetic copper-binding tripeptide (L-alanyl-L-histidyl-L-lysine + Cu²⁺); GHK-Cu sibling differing only by N-terminal a
WATCH-LIST P-P Well Researched
+ pep-pedia data merged →
ARA-290 (Cibinetide)
Both
Tissue-Protective Peptide | Innate Repair Receptor Agonist
WATCH-LIST P-P Emerging Research peptide-injectable
+ pep-pedia data merged →
Cartalax
Both
Russian-peptide (Khavinson short peptide bioregulator — synthetic tripeptide)
WATCH-LIST P-P Emerging Research
+ pep-pedia data merged →
Cyclic Glycine-Proline
Both
Endogenous cyclic dipeptide; IGF-1 homeostatic regulator (IGFBP-3 binding modulator); neuroprotective small-molecule sig
WATCH-LIST P-P Emerging Research
+ pep-pedia data merged →
DIHEXA
Both
Synaptogenic Peptide | Cognitive Enhancement & Neuroprotection
WATCH-LIST P-P Emerging Research peptide-injectable
+ pep-pedia data merged →
DSIP (Delta Sleep-Inducing Peptide)
Both
Endogenous neuropeptide — 9 amino acid (nonapeptide) sleep
WATCH-LIST P-P Emerging Research
+ pep-pedia data merged →
Epithalon (Epitalon / Epithalamin tetrapeptide)
Both
Synthetic Pineal Tetrapeptide | Telomerase Activator & Anti-Aging
WATCH-LIST P-P Well Researched peptide-injectable
+ pep-pedia data merged →
FOXO4-DRI
Both
Senolytic Peptide | FOXO4-p53 Disruption for Cellular Aging Research
WATCH-LIST P-P Emerging Research peptide-injectable
+ pep-pedia data merged →
Glutathione (GSH)
Both
Endogenous tripeptide antioxidant (gamma-Glu-Cys-Gly); master intracellular thiol; phase II conjugation cofactor; redox-
WATCH-LIST P-P Well Researched
+ pep-pedia data merged →
KLOW (peptide stack)
Both
Peptide stack — multi-component anti-inflammatory + regenerative blend (4-5 peptides depending on variant)
WATCH-LIST P-P Limited Research
+ pep-pedia data merged →
Melanotan-I (Afamelanotide)
Both
Linear 13-aa α-MSH analog and the FDA-approved cousin of MTII.
WATCH-LIST P-P FDA Approved peptide-injectable
+ pep-pedia data merged →
Omberacetam
Both
Russian dipeptide nootropic (proline-glycine prodrug → cycloprolylglycine; structurally racetam-adjacent but pharmacolog
WATCH-LIST P-P Emerging Research
+ pep-pedia data merged →
P21
Both
Synthetic neurogenic peptide (CNTF-derived adamantylated tetrapeptide derivative)
WATCH-LIST P-P Emerging Research
+ pep-pedia data merged →
PE-22-28
Both
TREK-1 Channel Blocker | Shortened Spadin Analog
WATCH-LIST P-P Emerging Research peptide-injectable
+ pep-pedia data merged →
Pinealon
Both
Synthetic Tripeptide | Neuroprotection & Cognitive Enhancement
WATCH-LIST P-P Well Researched peptide-injectable
+ pep-pedia data merged →
SLU-PP-332
Both
Small-molecule pan-agonist of estrogen-related receptors (ERRα
WATCH-LIST P-P Emerging Research
+ pep-pedia data merged →
Tesofensine
Both
Triple monoamine reuptake inhibitor (TRI) — DAT
WATCH-LIST P-P Well Researched
+ pep-pedia data merged →
Thymosin Alpha 1
Both
Synthetic 28-amino-acid thymic peptide
WATCH-LIST P-P Well Researched
+ pep-pedia data merged →
Thymulin
Both
Endogenous 9-amino-acid zinc-dependent metallopeptide thymic hormone
WATCH-LIST P-P Emerging Research
+ pep-pedia data merged →
Adamax
Both
Next-Generation Semax Derivative | Nootropic Neuropeptide
SKIP-FOR-NOW P-P Limited Research peptide-intranasal
+ pep-pedia data merged →
CJC-1295
Both
Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release
SKIP-FOR-NOW P-P Well Researched peptide-injectable
+ pep-pedia data merged →
CJC-1295 + Ipamorelin Protocol (CJC-IPA)
Both
Peptide stack — GHRH analog (CJC-1295) + selective GHRP
SKIP-FOR-NOW P-P Well Researched
+ pep-pedia data merged →
CJC-1295 with DAC
Both
Long-acting GHRH(1-29) analog with Drug Affinity Complex (DAC) — covalent albumin-tethered growth hormone secretagogue.
SKIP-FOR-NOW P-P Well Researched
+ pep-pedia data merged →
Follistatin
Both
Myostatin Inhibitor | TGF-β Antagonist for Muscle Research
SKIP-FOR-NOW P-P Emerging Research peptide-injectable
+ pep-pedia data merged →
GHRP-6
Both
Growth Hormone Secretagogue | GH Release & Cardioprotection
SKIP-FOR-NOW P-P Extensively Studied peptide-injectable
+ pep-pedia data merged →
Hexarelin
Both
Hexapeptide GHRP | Growth Hormone Release & Cardioprotection
SKIP-FOR-NOW P-P Well Researched peptide-injectable
+ pep-pedia data merged →
HGH (Human Growth Hormone)
Both
Human Growth Hormone | 191aa Recombinant Growth Hormone
SKIP-FOR-NOW P-P FDA Approved peptide-injectable
+ pep-pedia data merged →
IGF-1 (Insulin-like Growth Factor 1)
Both
Modified Growth Factor Analog | Research Chemical Only
SKIP-FOR-NOW P-P Limited Research peptide-injectable
+ pep-pedia data merged →
Ipamorelin
Both
Growth Hormone Secretagogue | Selective GHRP
SKIP-FOR-NOW P-P Well Researched peptide-injectable
+ pep-pedia data merged →
Melanotan II (MTII)
Both
Non-selective melanocortin agonist developed at University of Arizona (Hadley/Hruby lab, late 1980s) as a sunless-tannin
SKIP-FOR-NOW P-P Well Researched peptide-injectable
+ pep-pedia data merged →
MK-677 (Ibutamoren)
Both
Ghrelin Receptor Agonist | Growth Hormone Secretagogue
SKIP-FOR-NOW P-P Well Researched pill-oral-pharmaceutical
+ pep-pedia data merged →
Oxytocin (intranasal)
Both
Neurohypophysial Peptide | Social Bonding & Reproductive Hormone
SKIP-FOR-NOW P-P FDA Approved peptide-intranasal
+ pep-pedia data merged →
PEG-MGF (Pegylated Mechano Growth Factor)
Both
Anabolic peptide hormone — IGF-1Ec splice variant (C-terminal E-peptide). PEGylated for extended half-life. Functions as
SKIP-FOR-NOW P-P Limited Research
+ pep-pedia data merged →
Semaglutide
Both
GLP-1 Receptor Agonist | Weight Loss & Diabetes
SKIP-FOR-NOW P-P FDA Approved peptide-injectable
+ pep-pedia data merged →
Sermorelin
Both
GHRH 1-29 Analog | Growth Hormone Releasing Hormone
SKIP-FOR-NOW P-P Well Researched peptide-injectable
+ pep-pedia data merged →
Tesamorelin
Both
GHRH Analog | Visceral Fat Reduction
SKIP-FOR-NOW P-P FDA Approved peptide-injectable
+ pep-pedia data merged →
Adipotide
Both
19-amino-acid synthetic peptidomimetic — chimeric homing-effector molecule. N-terminal 9-aa sequence (CKGGRAKDC) is a pr
SKIP-PERMANENT P-P Emerging Research
+ pep-pedia data merged →
AOD-9604
Both
Synthetic 16-amino-acid modified C-terminal fragment of human growth hormone (hGH residues 177-191) with N-terminal tyro
SKIP-PERMANENT P-P Extensively Studied
+ pep-pedia data merged →
Retatrutide
Both
Triple GLP-1/GIP/Glucagon Agonist | Weight Loss & Diabetes
SKIP-PERMANENT P-P Extensively Studied peptide-injectable
+ pep-pedia data merged →
Bioglutide
Both
First-in-class oral small-molecule quadruple receptor agonist — IGF-1R + GLP-1R + GIP-R + glucagon-R simultaneously. Cyc
NOT-RELEVANT P-P Clinical Research
+ pep-pedia data merged →
Cagrilintide
Both
Long-acting acylated amylin analog (dual amylin receptor + calcitonin receptor agonist) — once-weekly subcutaneous. Inve
NOT-RELEVANT P-P Well Researched
+ pep-pedia data merged →
Cardiogen
Both
Russian-peptide
NOT-RELEVANT P-P Limited Research
+ pep-pedia data merged →
Fat Blaster
Both
Peptide stack (lipotropic injection blend — non-peptide micronutrients)
NOT-RELEVANT P-P Limited Research
+ pep-pedia data merged →
Human Chorionic Gonadotropin (hCG)
Both
Gonadotropin Hormone | LH Receptor Agonist
NOT-RELEVANT P-P FDA Approved peptide-injectable
+ pep-pedia data merged →
Kisspeptin
Both
Hypothalamic neuropeptide
NOT-RELEVANT P-P Emerging Research
+ pep-pedia data merged →
Lipo-C (Lipotropic Injection)
Both
Compounded lipotropic injection
NOT-RELEVANT P-P Limited Research
+ pep-pedia data merged →
LL-37 (Cathelicidin antimicrobial peptide)
Both
Endogenous 37-amino-acid amphipathic α-helical antimicrobial peptide; cathelicidin family (only human member); broad-spe
NOT-RELEVANT P-P Well Researched
+ pep-pedia data merged →
Mazdutide
Both
Dual incretin
NOT-RELEVANT P-P Extensively Studied
+ pep-pedia data merged →
Orforglipron
Both
Small-molecule (non-peptide) GLP-1 receptor agonist — once-daily oral tablet. The first orally bioavailable, fully non-p
NOT-RELEVANT P-P FDA Approved
+ pep-pedia data merged →
PNC-27
Both
Chimeric anticancer peptide (32-mer; p53 HDM-2-binding domain + Antennapedia penetratin)
NOT-RELEVANT P-P Emerging Research
+ pep-pedia data merged →
Prostamax
Both
Russian-peptide
NOT-RELEVANT P-P Limited Research
+ pep-pedia data merged →
PT-141 (Bremelanotide / Vyleesi)
Both
Synthetic cyclic heptapeptide melanocortin receptor agonist (MC4R-leaning, MC1R
NOT-RELEVANT P-P FDA Approved
+ pep-pedia data merged →
SNAP-8 (Acetyl Octapeptide-3)
Both
Cosmetic anti-wrinkle peptide
NOT-RELEVANT P-P Well Researched
+ pep-pedia data merged →
Survodutide
Both
Dual incretin
NOT-RELEVANT P-P Extensively Studied
+ pep-pedia data merged →
Testagen
Both
Russian-peptide
NOT-RELEVANT P-P Early Research
+ pep-pedia data merged →
Tirzepatide
Both
Dual GIP/GLP-1 Receptor Agonist | Weight Loss & Diabetes
NOT-RELEVANT P-P FDA Approved peptide-injectable
+ pep-pedia data merged →
VIP (Vasoactive Intestinal Peptide)
Both
Endogenous 28-amino-acid neuropeptide
NOT-RELEVANT P-P Clinical Research
+ pep-pedia data merged →
Carbamide Peroxide
Ours
Tooth-whitening prodrug — slow-release hydrogen peroxide; topical OTC + dental
CONFIRMED-IN-USE
Our research →
Castor Oil
Ours
Topical fatty acid (ricinoleic acid 85-95%) — natural plant oil; OTC cosmetic
CONFIRMED-IN-USE
Our research →
Citicoline (CDP-Choline)
Ours
Endogenous brain compound, dual-substrate cholinergic donor + Kennedy-pathway nucleotide — supplies both choline (for ac
CONFIRMED-IN-USE P-P Extensively Studied capsule-supplement
Our research →
Creatine (monohydrate)
Ours
The most-validated sports supplement in existence and now — post-Forsberg 2024 — a credible cognitive tool for sleep dep
CONFIRMED-IN-USE P-P Extensively Studied powder-supplement
Our research →
Curcumin
Ours
Best-studied anti-inflammatory polyphenol on Earth, with replicated A-tier evidence in knee OA pain, depression adjunct,
CONFIRMED-IN-USE P-P Extensively Studied capsule-supplement
Our research →
Hydrogen Peroxide (H2O2)
Ours
Reactive oxygen species (ROS)
CONFIRMED-IN-USE
Our research →
Hydroxyapatite
Ours
Calcium phosphate biomineral — natural bone
CONFIRMED-IN-USE
Our research →
Magnesium L-Threonate (Magtein)
Ours
Magnesium salt
CONFIRMED-IN-USE
Our research →
N-Acetyl-Cysteine (NAC)
Ours
Cheap, daily-safe glutathione precursor with massive evidence base — FDA-approved for paracetamol overdose (gold-standar
CONFIRMED-IN-USE P-P Extensively Studied powder-supplement
Our research →
Rhodiola rosea
Ours
Adaptogen — Crassulaceae root extract; standardized to rosavins and salidrosides
CONFIRMED-IN-USE
Our research →
Modafinil
Ours
Best evidence-base eugeroic on the planet for sustained cognitive output without amphetamine downsides — 100mg AM, 5-6×/
PRIMARY-PICK P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Armodafinil
Ours
R-enantiomer-only modafinil with smoother monophasic decline, ~33-40% higher AUC mg-for-mg, and Tmax 3-4 hr later than r
STRONG-CANDIDATE P-P Well Researched pill-oral-pharmaceutical
Our research →
Astaxanthin
Ours
Cheap, near-zero-risk daily antioxidant that crosses the BBB and blood-retinal barrier.
STRONG-CANDIDATE P-P Extensively Studied capsule-supplement
Our research →
Caffeine
Ours
The world's most-used cognitive + ergogenic drug, A-tier across cognition, endurance, strength, and combat-sport reactio
STRONG-CANDIDATE P-P Extensively Studied other-hybrid
Our research →
High-Dose Creatine Cognition Protocol (20 g acute / loading-tier brain-saturation)
Ours
Protocol — acute high-dose creatine monohydrate for brain saturation and cognitive rescue (distinct from baseline 5 g
STRONG-CANDIDATE
Our research →
L-Theanine
Ours
Glutamate analog with partial NMDA modulation, GABA bumping, and reliable alpha-wave EEG induction at 200 mg.
STRONG-CANDIDATE P-P Extensively Studied powder-supplement
Our research →
L-Tryptophan
Ours
Cheap, well-evidenced, regulated serotonin → melatonin precursor for sleep onset and mood support.
STRONG-CANDIDATE P-P Extensively Studied powder-supplement
Our research →
Melatonin
Ours
Endogenous pineal hormone, OTC supplement — but the dose and timing matter more than the molecule.
STRONG-CANDIDATE P-P Extensively Studied capsule-supplement
Our research →
Phenylpiracetam
Ours
Russian-developed phenyl-substituted piracetam analog created in 1983 for Soviet cosmonauts — the only racetam on the WA
STRONG-CANDIDATE P-P Well Researched pill-oral-pharmaceutical
Our research →
Selegiline
Ours
Three different drugs in one molecule depending on dose: low oral (1-2.5 mg) is a clean, daily-safe MAO-B preservation t
STRONG-CANDIDATE P-P Well Researched pill-oral-pharmaceutical
Our research →
Taurine
Ours
Cheap, broad-spectrum amino acid with A-tier evidence for cardiovascular function (BP, heart rate, LVEF in heart failure
STRONG-CANDIDATE P-P Extensively Studied powder-supplement
Our research →
3-n-Butylphthalide (NBP)
Ours
Chinese-approved multi-target neuroprotectant derived from celery seed; A-tier evidence in China for acute ischemic stro
OPTIONAL-ADD P-P Well Researched pill-oral-pharmaceutical
Our research →
7,8-Dihydroxyflavone
Ours
Flavonoid
OPTIONAL-ADD
Our research →
Agmatine Sulfate
Ours
Endogenous arginine metabolite with a multi-receptor footprint — modest NMDA antagonism (GluN2B-preferring), imidazoline
OPTIONAL-ADD P-P Well Researched powder-supplement
Our research →
Alpha-GPC (L-Alpha-Glycerylphosphorylcholine)
Ours
The fastest-onset, highest-bioavailability choline donor in the consumer market — 41% choline by weight, peak plasma cho
OPTIONAL-ADD P-P Well Researched capsule-supplement
Our research →
Aniracetam
Ours
First-generation lipophilic racetam (Hoffmann-La Roche, 1970s).
OPTIONAL-ADD P-P Well Researched pill-oral-pharmaceutical
Our research →
Apigenin
Ours
Cheap, low-risk flavonoid with a real mechanism story (CD38 inhibition → NAD+ preservation, GABA-A → mild calming, senom
OPTIONAL-ADD P-P Well Researched capsule-supplement
Our research →
Ashwagandha
Ours
Adaptogen — withanolide-rich Solanaceae root extract; HPA-axis modulator
OPTIONAL-ADD
Our research →
Ashwagandha KSM-66
Ours
Adaptogen — Withania somnifera root-only extract; standardized to ~5% withanolides; HPA-axis modulator
OPTIONAL-ADD
Our research →
Ashwagandha Sensoril
Ours
Adaptogen — Withania somnifera root + leaf extract; standardized to ~10% withanolides; HPA-axis modulator
OPTIONAL-ADD
Our research →
Bacopa monnieri
Ours
The best-evidenced traditional adaptogen for memory consolidation and delayed recall — A-tier replicated RCTs in healthy
OPTIONAL-ADD P-P Well Researched capsule-supplement
Our research →
Bupropion
Ours
NDRI antidepressant that hits dopamine + norepinephrine without serotonin — clean motivation, drive, and anhedonia relie
OPTIONAL-ADD P-P Well Researched pill-oral-pharmaceutical
Our research →
Carnosic Acid
Ours
Cheap, daily-safe, BBB-crossing rosemary diterpene that is the cleanest "pro-electrophilic" Nrf2 activator we have — it'
OPTIONAL-ADD P-P Well Researched capsule-supplement
Our research →
Citrulline Malate
Ours
Amino acid
OPTIONAL-ADD
Our research →
Coluracetam
Ours
The only racetam that traffics the choline transporter itself (CHT1/SLC5A7 to the synaptic membrane) instead of modulati
OPTIONAL-ADD P-P Well Researched pill-oral-pharmaceutical
Our research →
Eleuthero (Siberian Ginseng)
Ours
Adaptogen — Araliaceae root extract; eleutheroside-rich; classical Russian adaptogen
OPTIONAL-ADD
Our research →
Fasoracetam (NS-105)
Ours
Fourth-generation racetam originally synthesized by Nippon Shinyaku in the late 1980s (NS-105), failed Phase 3 in vascul
OPTIONAL-ADD P-P Well Researched pill-oral-pharmaceutical
Our research →
Glycine
Ours
Cheapest amino acid supplement on the shelf with two real but limited use cases: (1) 3 g pre-bed for subjectively better
OPTIONAL-ADD P-P Well Researched powder-supplement
Our research →
Huperzine A
Ours
Highly selective, reversible, BBB-penetrant AChE inhibitor extracted from Chinese club moss — 25-100× more potent than d
OPTIONAL-ADD P-P Well Researched capsule-supplement
Our research →
Idebenone
Ours
Synthetic short-chain CoQ10 analog that actually crosses the BBB (regular CoQ10 mostly cannot), shuttles electrons to ET
OPTIONAL-ADD P-P Well Researched capsule-supplement
Our research →
L-Glutamine
Ours
Most abundant free amino acid in plasma and skeletal muscle; conditionally essential during catabolic stress.
OPTIONAL-ADD P-P Emerging powder-supplement
Our research →
L-Tyrosine
Ours
Cheap amino-acid precursor to dopamine, norepinephrine, and epinephrine that only works when those neurotransmitters are
OPTIONAL-ADD P-P Extensively Studied powder-supplement
Our research →
Lion's Mane (Hericium erinaceus)
Ours
Mainstream "smart mushroom" with a real but highly fraction-dependent mechanism: erinacines (mycelium) cross the BBB and
OPTIONAL-ADD P-P Well Researched capsule-supplement
Our research →
Lithium Orotate (low-dose nutrient lithium)
Ours
Low-dose lithium orotate (5-20 mg elemental Li/day) is a different drug from prescription lithium carbonate (600-1500 mg
OPTIONAL-ADD P-P Well Researched capsule-supplement
Our research →
Memantine
Ours
Uncompetitive, fast-off-rate NMDA channel blocker that uniquely intercepts pathological glutamate excitotoxicity while l
OPTIONAL-ADD P-P Well Researched pill-oral-pharmaceutical
Our research →
Methylene Blue (USP grade)
Ours
Genuinely unique mechanism (alternative mitochondrial electron carrier that bypasses complex I/III blockade) with strict
OPTIONAL-ADD P-P Well Researched capsule-supplement
Our research →
N-Acetyl-L-Tyrosine
Ours
Acetylated amino acid
OPTIONAL-ADD
Our research →
Naltrexone (Standard-dose + Low-Dose / LDN)
Ours
Naltrexone is two different drugs at two different doses.
OPTIONAL-ADD P-P Well Researched pill-oral-pharmaceutical
Our research →
Nefiracetam
Ours
Daiichi Seiyaku's "anti-apathy" racetam (DM-9384) — piracetam analog with a 2,6-dimethylphenyl group that gives it uniqu
OPTIONAL-ADD P-P Well Researched pill-oral-pharmaceutical
Our research →
Niacinamide
Ours
Vitamin B3 — amide form (NAD+ precursor)
OPTIONAL-ADD
Our research →
Oxiracetam
Ours
Mild, energetic, "logical-analytical" racetam — Italy's Phase III/IV clinical heritage gave it a vascular-dementia label
OPTIONAL-ADD P-P Well Researched pill-oral-pharmaceutical
Our research →
Panax Ginseng (Asian / Korean Ginseng)
Ours
Adaptogen — Araliaceae root extract; ginsenoside-rich; classical Chinese
OPTIONAL-ADD
Our research →
Paraxanthine
Ours
Caffeine's main active metabolite, sold direct as ENFINITY — what your liver makes anyway when you drink coffee, but ski
OPTIONAL-ADD P-P Well Researched capsule-supplement
Our research →
Phenylethylamine (PEA)
Ours
Trace amine — endogenous CNS neuromodulator; releases dopamine and norepinephrine
OPTIONAL-ADD
Our research →
Picamilon
Ours
Soviet-era (1969) prodrug — GABA covalently bonded to niacin so the conjugate can cross the blood-brain barrier, where i
OPTIONAL-ADD P-P Well Researched pill-oral-pharmaceutical
Our research →
Pine Bark Extract
Ours
Standardized polyphenol extract — oligomeric proanthocyanidins (OPCs
OPTIONAL-ADD
Our research →
Piracetam
Ours
The parent racetam and original nootropic — Corneliu Giurgea synthesized it at UCB Belgium in 1964 and coined the word "
OPTIONAL-ADD P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Pramiracetam
Ours
Most potent classical racetam by weight (~10–30× piracetam) with a clean, distinctive HACU-enhancement mechanism that bo
OPTIONAL-ADD P-P Well Researched pill-oral-pharmaceutical
Our research →
Propranolol
Ours
Cheap, generic, non-selective beta-blocker that shuts off the peripheral adrenergic symptoms of stage fright (racing hea
OPTIONAL-ADD P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Schisandra
Ours
Adaptogen — Schisandraceae berry extract; lignan-rich (schisandrins, schizandrins, gomisins)
OPTIONAL-ADD
Our research →
Spermidine
Ours
Polyamine that induces autophagy — the cellular self-cleaning pathway that's the most mechanistically defensible aging l
OPTIONAL-ADD P-P Emerging capsule-supplement
Our research →
Sulbutiamine
Ours
Lipid-soluble synthetic dimer of thiamine that crosses the BBB and raises brain thiamine plus pyrophosphate; chronic dos
OPTIONAL-ADD P-P Well Researched capsule-supplement
Our research →
Tadalafil
Ours
Long-half-life PDE5 inhibitor (17.5 hr) that turns into a smooth daily background vasodilator at 2.5-5 mg — the only PDE
OPTIONAL-ADD P-P Well Researched pill-oral-pharmaceutical
Our research →
Tetramethoxyluteolin
Ours
Methylated flavonoid — luteolin O-methyl analog; mast-cell stabilizer with brain-penetrant pharmacokinetics
OPTIONAL-ADD
Our research →
Tretinoin (all-trans retinoic acid)
Ours
Tretinoin is the gold-standard topical retinoid since 1971, with A-tier evidence for acne (any concentration) and photoa
OPTIONAL-ADD P-P Emerging topical
Our research →
Ubiquinol
Ours
Ubiquinol is the reduced/active form of coenzyme Q10 — your mitochondrial electron-transport workhorse and the principal
OPTIONAL-ADD P-P Extensively Studied capsule-supplement
Our research →
Urolithin A
Ours
Urolithin A is a small molecule your gut bacteria normally make from ellagitannins (pomegranate, walnut, certain berries
OPTIONAL-ADD P-P Well Researched capsule-supplement
Our research →
Vitamin B-Complex (B1/B2/B3/B5/B6/B7/B9/B12)
Ours
Water-soluble vitamin cofactor stack
OPTIONAL-ADD
Our research →
9-Methyl-β-carboline
Ours
Polanski lab's 2007-2020 preclinical work (rat + primary cell culture) shows 9-Me-BC does an unusually long list of usef
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
ACD-856
Ours
First-in-class small-molecule positive allosteric modulator of all three Trk receptors (TrkA/TrkB/TrkC) — the receptors
WATCH-LIST P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Agomelatine
Ours
First-in-class melatonergic antidepressant (MT1/MT2 agonist + 5-HT2C antagonist) — sleep-promoting at night, mood-bright
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
BPAP
Ours
The cleanest theoretical successor to selegiline that exists on paper — pure catecholaminergic (and serotonergic) activi
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
BPN14770 (Zatolmilast)
Ours
First-in-class PDE4D negative allosteric modulator developed by Tetra Discovery Partners (Grand Rapids, MI) and acquired
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
Clonidine
Ours
Generic, cheap, non-selective α2-adrenergic agonist that shuts down central sympathetic outflow — heavy sedation, lower
WATCH-LIST P-P Emerging pill-oral-pharmaceutical
Our research →
Daridorexant
Ours
Best-in-class dual orexin receptor antagonist for next-day cognition: 8-hour half-life clears before morning, preserves
WATCH-LIST P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Galantamine
Ours
Plant alkaloid from the snowdrop (Galanthus nivalis) with a dual mechanism that none of Dylan's other cholinergics share
WATCH-LIST P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Humanin
Ours
A 24-amino-acid peptide your own mitochondria make (encoded inside the 16S rRNA gene MT-RNR2) — the first-discovered…
WATCH-LIST P-P Emerging peptide-injectable
Our research →
Intranasal Insulin
Ours
Off-label use of regular human insulin (Humulin R, NovoLog) delivered via specialized intranasal atomizer to reach brain
WATCH-LIST P-P Well Researched peptide-intranasal
Our research →
ISRIB
Ours
ISRIB is a 2013 UCSF tool compound (Sidrauski / Walter lab) that allosterically activates eIF2B and reverses the chronic
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
Ketamine
Ours
Schedule III dissociative anesthetic and the most consequential rapid-antidepressant breakthrough of the 21st century —
WATCH-LIST P-P Extensively Studied pill-oral-pharmaceutical
Our research →
KW-6356
Ours
Kyowa Kirin's discontinued second-generation A2A inverse agonist — 100x istradefylline affinity, longer receptor residen
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
Melatonin (HIGH-DOSE — antioxidant / oncology / neuroprotection use)
Ours
At 20-300 mg, melatonin is no longer a sleep hormone — it is a lipid-soluble, mitochondria-accumulating antioxidant with
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
Metformin
Ours
Biguanide
WATCH-LIST
Our research →
NACET (N-Acetylcysteine Ethyl Ester)
Ours
The lipophilic ethyl ester of NAC — solves the main pharmacokinetic weakness of parent NAC by crossing the blood-brain b
WATCH-LIST P-P Emerging capsule-supplement
Our research →
Nicotine
Ours
Nicotine gum/lozenge at 2-4 mg has real, A-tier cognitive evidence (Heishman 2010 meta: fine motor, alerting attention,
WATCH-LIST P-P Extensively Studied other-hybrid
Our research →
Nimodipine
Ours
Selective L-type calcium channel blocker (CCB) with the highest BBB penetration of any clinical CCB; FDA-approved 1988 f
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
Noopept
Ours
Russian dipeptide nootropic developed at the Zakusov Institute (Ostrovskaya lab, late-1990s, registered 2002) — orally-a
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
NSI-189
Ours
Synthetic small molecule originally from Neuralstem that genuinely promotes hippocampal neurogenesis in animals (~36-66%
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
PRL-8-53
Ours
A 47-year-old curiosity.
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
Seltorexant
Ours
Investigational selective OX2-only orexin antagonist from Johnson & Johnson / Minerva Neurosciences, currently in Phase
WATCH-LIST P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Solriamfetol
Ours
DNRI wakefulness drug from Axsome (acquired Sunosi from Jazz Pharma in 2022) — A-tier evidence in narcolepsy + OSA EDS,
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
Sunifiram
Ours
Ampakine-like piperazine derivative (functionally related to racetams; not a true racetam structurally)
WATCH-LIST
Our research →
TAK-653 (Osavampator)
Ours
First-in-class selective AMPA receptor PAM (slows AMPA receptor desensitization without directly agonizing the resting r
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
Tropisetron
Ours
A serotonin-3 (5-HT3) antagonist marketed in EU/Asia as the chemotherapy anti-emetic Navoban that also acts as a partial
WATCH-LIST P-P Well Researched pill-oral-pharmaceutical
Our research →
5-HTP
Ours
Cheap OTC serotonin precursor that skips the rate-limiting tryptophan hydroxylase (TPH) step and the kynurenine quality-
SKIP-FOR-NOW P-P Emerging powder-supplement
Our research →
Adderall
Ours
SKIP-FOR-NOW for Dylan at 20 — the brain-development concern (real for stimulants in <25yo with chronic use), appetite s
SKIP-FOR-NOW P-P Well Researched pill-oral-pharmaceutical
Our research →
AF710B
Ours
Anavex's M1-PAM + sigma-1 dual agonist, originally synthesized at Israel's IIBR by Abraham Fisher's group, then licensed
SKIP-FOR-NOW P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Atomoxetine
Ours
Selective NRI — the only FDA-approved non-stimulant ADHD med for adults; A-tier for ADHD (effect size ~0.45 vs placebo,
SKIP-FOR-NOW P-P Emerging pill-oral-pharmaceutical
Our research →
Baclofen
Ours
Selective GABA-B agonist with A-tier evidence for MS / spinal-cord spasticity (FDA-approved 1977), B-tier evidence for a
SKIP-FOR-NOW P-P Emerging pill-oral-pharmaceutical
Our research →
Boldenone Undecylenate
Ours
Veterinary-equine AAS — testosterone with an added 1,2-double bond, esterified to undecylenate for ~14-day half-life.
SKIP-FOR-NOW P-P Well Researched aas-oil-injectable
Our research →
Buspirone
Ours
Azapirone — partial 5-HT1A receptor agonist; non-benzodiazepine anxiolytic
SKIP-FOR-NOW
Our research →
Cerluten
Ours
Khavinson-framework liver "bioregulator" peptide.
SKIP-FOR-NOW P-P Emerging peptide-injectable
Our research →
Concerta
Ours
Janssen's once-daily 12-hour OROS extended-release methylphenidate — same drug as Ritalin, smarter delivery (osmotic pum
SKIP-FOR-NOW P-P Emerging pill-oral-pharmaceutical
Our research →
Cortexin
Ours
Russian Rx neurology drug (registered since 1999) — a lyophilized hydrolysate of bovine or porcine cerebral cortex pepti
SKIP-FOR-NOW P-P Emerging peptide-injectable
Our research →
Dexedrine
Ours
Pure d-amphetamine — same active drug as Vyvanse but without prodrug protection, slightly cleaner peripheral profile tha
SKIP-FOR-NOW P-P Emerging pill-oral-pharmaceutical
Our research →
DHEA (Dehydroepiandrosterone)
Ours
Endogenous adrenal precursor to testosterone and estradiol.
SKIP-FOR-NOW P-P Emerging capsule-supplement
Our research →
Donepezil (Aricept)
Ours
The most-prescribed Alzheimer's drug in the world (FDA-approved 1996) — a piperidine-class reversible, highly selective
SKIP-FOR-NOW P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Dutasteride
Ours
Dual 5α-reductase inhibitor — knocks DHT down ~95%.
SKIP-FOR-NOW P-P Emerging pill-oral-pharmaceutical
Our research →
Enclomiphene Citrate
Ours
Trans-isomer of clomiphene that boosts endogenous testosterone via HPG-axis stimulation (LH/FSH up, T up, fertility pres
SKIP-FOR-NOW P-P Well Researched pill-oral-pharmaceutical
Our research →
Evekeo
Ours
SKIP-FOR-NOW for Dylan — same family rationale as Adderall, refer to that file as parent analysis.
SKIP-FOR-NOW P-P Emerging pill-oral-pharmaceutical
Our research →
Fladrafinil
Ours
Lafon-era research compound (CRL-40,941) — the bisfluoro analog of adrafinil that never made it past 1970s-80s animal ph
SKIP-FOR-NOW P-P Emerging pill-oral-pharmaceutical
Our research →
Focalin (Dexmethylphenidate)
Ours
Pure d-isomer of methylphenidate — twice as potent per mg as racemic Ritalin, "cleaner" subjective signature, but mechan
SKIP-FOR-NOW P-P Emerging pill-oral-pharmaceutical
Our research →
Follistatin-344 (FS-344)
Ours
Myostatin
SKIP-FOR-NOW
Our research →
Forskolin
Ours
Forskolin is the textbook direct adenylyl-cyclase activator — beautiful mechanism, every pharmacology class uses it.
SKIP-FOR-NOW P-P Emerging capsule-supplement
Our research →
GHRP-2
Ours
Older-generation, non-selective ghrelin-receptor agonist that produces a stronger GH pulse than ipamorelin but also rais
SKIP-FOR-NOW P-P Emerging peptide-injectable
Our research →
Guanfacine
Ours
Selective α2A-adrenergic agonist (Shire/Takeda's Intuniv ER) — A-tier evidence as ADHD adjunct in kids/adolescents, B-ti
SKIP-FOR-NOW P-P Extensively Studied pill-oral-pharmaceutical
Our research →
IDRA-21
Ours
Ampakine — AMPA receptor positive allosteric modulator (Type II
SKIP-FOR-NOW
Our research →
IGF-1 LR3 (Long Arg3 Insulin-like Growth Factor 1)
Ours
Modified IGF-1 analog — 83-amino-acid recombinant peptide with N-terminal 13-residue extension + Arg-3 substitution. Lon
SKIP-FOR-NOW
Our research →
Isotretinoin
Ours
The nuclear option for severe acne — a systemic vitamin A derivative (13-cis-retinoic acid) that shrinks sebaceous gland
SKIP-FOR-NOW P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Lemborexant
Ours
Eisai's DORA — the only sleep drug that has objectively beaten zolpidem-ER head-to-head (SUNRISE-1) on sleep onset, with
SKIP-FOR-NOW P-P Extensively Studied pill-oral-pharmaceutical
Our research →
LGD-4033 (Ligandrol)
Ours
Nonsteroidal SARM developed by Ligand Pharma (later licensed to Viking as VK5211) for muscle wasting; reliably builds le
SKIP-FOR-NOW P-P Extensively Studied sarm-oral
Our research →
Liposomal Glutathione
Ours
Phospholipid-encapsulated GSH does fix the GI bioavailability problem of plain glutathione (B-tier evidence: Sinha 2018
SKIP-FOR-NOW P-P Emerging capsule-supplement
Our research →
Lisuride
Ours
Direct ergoline dopamine agonist (D1-D5) that bypasses the cardiac valvulopathy problem of pergolide/cabergoline by bein
SKIP-FOR-NOW P-P Extensively Studied pill-oral-pharmaceutical
Our research →
LSD
Ours
The original psychoplastogen — a Schedule I 5-HT2A partial agonist with strong A-tier macrodose evidence for treatment-r
SKIP-FOR-NOW P-P Extensively Studied sublingual-lozenge
Our research →
Masteron Enanthate
Ours
Masteron enanthate is a long-ester DHT-derivative AAS originally developed as a chemotherapy adjunct for breast cancer (
SKIP-FOR-NOW P-P Emerging aas-oil-injectable
Our research →
Methenolone
Ours
Mild DHT-derived AAS with a "clean" reputation — non-aromatizing, low androgenic, decent body comp.
SKIP-FOR-NOW P-P Emerging aas-oil-injectable
Our research →
Methylin
Ours
Methylin = Ritalin IR with a different label on the bottle.
SKIP-FOR-NOW P-P Emerging pill-oral-pharmaceutical
Our research →
Minoxidil
Ours
A K+ channel-opening vasodilator originally approved for severe hypertension that grew hair as a side effect, then got r
SKIP-FOR-NOW P-P Extensively Studied topical
Our research →
Mirtazapine
Ours
Tetracyclic NaSSA developed by Organon in the 1990s — α2 antagonist + 5-HT2A/2C/3 antagonist + potent H1 antagonist.
SKIP-FOR-NOW P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Muscimol
Ours
Direct GABA-A agonist from Amanita muscaria — rare mechanism (most "GABAergics" are PAMs), but the actual experience is
SKIP-FOR-NOW P-P Extensively Studied capsule-supplement
Our research →
Mydayis
Ours
SKIP-FOR-NOW for Dylan with HIGH confidence.
SKIP-FOR-NOW P-P Emerging pill-oral-pharmaceutical
Our research →
Neboglamine
Ours
Italian-origin (Rottapharm) glutamic-acid-derived positive allosteric modulator at an allosteric site of the NMDA glycin
SKIP-FOR-NOW P-P Well Researched pill-oral-pharmaceutical
Our research →
Ostarine
Ours
Non-steroidal SARM with bone/muscle tropism — milder than LGD-4033 in both efficacy and HPG suppression, but not innocen
SKIP-FOR-NOW P-P Extensively Studied sarm-oral
Our research →
Oxandrolone
Ours
Oxandrolone is the canonical "mild" oral anabolic-androgenic steroid — a 17α-alkylated DHT-derivative originally develop
SKIP-FOR-NOW P-P Extensively Studied aas-oral
Our research →
Pitolisant
Ours
First-in-class histamine H3 inverse agonist from Bioprojet (EU 2016) / Harmony Biosciences (US 2019, expanded 2020 catap
SKIP-FOR-NOW P-P Well Researched pill-oral-pharmaceutical
Our research →
PPAP
Ours
Historical-interest compound, not a current pick.
SKIP-FOR-NOW P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Qelbree (viloxazine ER)
Ours
Newer (FDA 2021 pediatric, 2022 adult) non-stimulant ADHD drug from Supernus — repurposed European antidepressant (1970s
SKIP-FOR-NOW P-P Well Researched pill-oral-pharmaceutical
Our research →
RAD-140 (Testolone)
Ours
Most potent of the common SARMs — strong body comp gains but the harshest HPG suppression in the class plus documented h
SKIP-FOR-NOW P-P Emerging sarm-oral
Our research →
Ritalin
Ours
Cheap, 70-year-evidenced racemic stimulant for ADHD.
SKIP-FOR-NOW P-P Emerging pill-oral-pharmaceutical
Our research →
Roflumilast
Ours
Roflumilast is the FDA-approved oral PDE4 inhibitor for severe COPD (Daliresp, 2011) and the topical FDA-approved PDE4 i
SKIP-FOR-NOW P-P Extensively Studied pill-oral-pharmaceutical
Our research →
RU58841
Ours
A topical-only, non-steroidal androgen receptor antagonist designed in the 1980s-90s by Roussel-Uclaf for prostate cance
SKIP-FOR-NOW P-P Emerging topical
Our research →
S-Acetyl-Glutathione
Ours
Acetylated, GI-stable form of glutathione (GSH) that improves oral bioavailability over plain GSH by ~13× in plasma AUC
SKIP-FOR-NOW P-P Theoretical capsule-supplement
Our research →
Sarcosine
Ours
Sarcosine (N-methylglycine) is a GlyT1 inhibitor + NMDA glycine-site partial agonist with A-tier evidence as a schizophr
SKIP-FOR-NOW P-P Emerging powder-supplement
Our research →
Suvorexant
Ours
First-approved DORA (Merck 2014, FDA-cleared, AASM-recommended), with the deepest post-market dataset of the class — and
SKIP-FOR-NOW P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Synapsin
Ours
Compounded intranasal blend of ginsenoside Rg3 + nicotinamide riboside (NR) — not Rg3 + ALCAR as Dylan's brief stated; t
SKIP-FOR-NOW P-P Emerging peptide-intranasal
Our research →
Testosterone Cypionate
Ours
Testosterone cypionate (Depo-Testosterone) is the US-dominant long-ester injectable testosterone — pharmacologically ind
SKIP-FOR-NOW P-P Extensively Studied aas-oil-injectable
Our research →
Testosterone Enanthate
Ours
Bioidentical testosterone in oil depot — gold-standard TRT for documented hypogonadism, but a HPG-suppressing supraphysi
SKIP-FOR-NOW P-P Emerging aas-oil-injectable
Our research →
THN102
Ours
Theranexus's now-discontinued fixed-dose combination of modafinil + sub-antiarrhythmic flecainide.
SKIP-FOR-NOW P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Trazodone
Ours
Atypical sedating antidepressant whose off-label use for insomnia (US) outpaces its on-label antidepressant use — primar
SKIP-FOR-NOW P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Vesugen
Ours
Khavinson tripeptide (Lys-Glu-Asp / KED) marketed as a "vascular bioregulator." Mechanism is thin (one DNA-binding-style
SKIP-FOR-NOW P-P Emerging peptide-injectable
Our research →
Vyvanse
Ours
Smoothest amphetamine PK in the class — L-lysine peptide bond is cleaved by red-blood-cell aminopeptidase to release d-a
SKIP-FOR-NOW P-P Well Researched pill-oral-pharmaceutical
Our research →
Adrafinil
Ours
Modafinil prodrug from the 1980s, withdrawn from French market 2011 for an unfavorable risk-benefit ratio (hepatotoxicit
SKIP-PERMANENT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Benzodiazepines (drug class)
Ours
First synthesized accidentally by Leo Sternbach at Hoffmann-La Roche in 1955 (chlordiazepoxide / Librium, found in a 195
SKIP-PERMANENT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Desoxyn
Ours
SKIP-PERMANENT for Dylan.
SKIP-PERMANENT P-P Emerging pill-oral-pharmaceutical
Our research →
Fluoxymesterone
Ours
17α-methylated halogenated testosterone derivative — Upjohn-era oral AAS, used historically for combat-sport pre-fight a
SKIP-PERMANENT P-P Emerging aas-oral
Our research →
GABA (oral supplement)
Ours
Endogenous brain neurotransmitter sold as a $0.10/dose dietary supplement.
SKIP-PERMANENT P-P Extensively Studied capsule-supplement
Our research →
Gabapentin
Ours
Gabapentin is a 1974 Goedecke/Parke-Davis lipophilic GABA analog that turned out to have nothing to do with GABA — it bi
SKIP-PERMANENT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
GHB / GBL
Ours
GHB is an endogenous GABA metabolite and the most narrow-therapeutic-window CNS depressant in common use — recreational
SKIP-PERMANENT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Imuracetam
Ours
Racetam (2-pyrrolidinone derivative) — abandoned 1970s development candidate
SKIP-PERMANENT
Our research →
Methyltestosterone
Ours
The oldest oral anabolic steroid (synthesized 1935, marketed late 1930s), and now obsolete.
SKIP-PERMANENT P-P Emerging aas-oral
Our research →
Methyltrienolone
Ours
17α-methylated trenbolone — the oral version of the most potent mainstream injectable AAS, sold via gray-market UGLs and
SKIP-PERMANENT P-P Extensively Studied aas-oral
Our research →
Novolin R (regular human insulin)
Ours
Short-acting recombinant human insulin (hexameric)
SKIP-PERMANENT
Our research →
Phenibut
Ours
Russian Rx anxiolytic (1960s, Perekalin lab, Leningrad) marketed in the West as a benign "supplement" that, in reality,
SKIP-PERMANENT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Pregabalin
Ours
Lyrica is a calcium-channel modulator (α2δ subunit) — same family as gabapentin but ~6× more potent and faster-onset.
SKIP-PERMANENT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Seletracetam
Ours
Discontinued UCB Pharma research compound.
SKIP-PERMANENT P-P Emerging pill-oral-pharmaceutical
Our research →
Teriparatide
Ours
Recombinant PTH 1-34 — first true bone-ANABOLIC drug, given as daily SC injection up to 2 years for severe osteoporosis.
SKIP-PERMANENT P-P Emerging peptide-injectable
Our research →
Tianeptine
Ours
Functionally a μ-opioid agonist sold as an "antidepressant nootropic" — at biohacker doses it produces opioid-tier eupho
SKIP-PERMANENT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Trenbolone
Ours
Veterinary cattle implant repurposed as the most potent mainstream AAS in bodybuilding.
SKIP-PERMANENT P-P Emerging aas-oil-injectable
Our research →
Trenbolone Enanthate
Ours
Trenbolone delivered as a long-acting enanthate ester (~5-7 day half-life) so users can inject 1-2× weekly instead of ev
SKIP-PERMANENT P-P Extensively Studied aas-oil-injectable
Our research →
Trestolone
Ours
Population Council male contraceptive candidate — that's the giveaway.
SKIP-PERMANENT P-P Extensively Studied aas-oil-injectable
Our research →
Z-Drugs (zolpidem, zaleplon, eszopiclone, zopiclone)
Ours
Non-benzo GABA-A α1-preferring sedatives marketed 1992–2004 as "cleaner benzos for sleep." They are not.
SKIP-PERMANENT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Abaloparatide
Ours
Bone-anabolic peptide
NOT-RELEVANT
Our research →
Anastrozole
Ours
Third-generation non-steroidal aromatase inhibitor — FDA-approved 1995 for postmenopausal HR+ breast cancer, off-label w
NOT-RELEVANT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
BMP-2 (Bone Morphogenetic Protein 2)
Ours
Recombinant growth factor (TGF-β superfamily)
NOT-RELEVANT
Our research →
Brivaracetam
Ours
UCB Pharma's structurally optimized successor to levetiracetam — same SV2A target, 15-30× higher binding affinity, same
NOT-RELEVANT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Daytrana
Ours
Methylphenidate transdermal patch — same drug as Ritalin, delivered through skin via a 9-hour wear-and-remove patch.
NOT-RELEVANT P-P Extensively Studied topical
Our research →
Duloxetine
Ours
SNRI (serotonin-norepinephrine reuptake inhibitor)
NOT-RELEVANT
Our research →
Eplerenone
Ours
Selective mineralocorticoid receptor antagonist — blocks aldosterone's effects on the kidney and vasculature without spi
NOT-RELEVANT P-P Emerging pill-oral-pharmaceutical
Our research →
Escitalopram
Ours
SSRI (S-enantiomer of citalopram)
NOT-RELEVANT
Our research →
Ezetimibe
Ours
Selective NPC1L1 inhibitor that blocks intestinal cholesterol absorption — the only mechanistically distinct lipid-lower
NOT-RELEVANT P-P Emerging pill-oral-pharmaceutical
Our research →
FGFR3-targeted therapeutics (vosoritide / infigratinib / sotuletinib)
Ours
FGFR3 modulators — CNP analog (vosoritide) or small-molecule FGFR1-4 tyrosine kinase inhibitors
NOT-RELEVANT
Our research →
Fluoxetine
Ours
SSRI (selective serotonin reuptake inhibitor)
NOT-RELEVANT
Our research →
GB-115
Ours
Russian dipeptide CCK-B receptor antagonist developed at the Zakusov Institute (Seredenin / Garibova lab).
NOT-RELEVANT P-P Emerging peptide-intranasal
Our research →
Hydrochlorothiazide (HCTZ)
Ours
Thiazide diuretic
NOT-RELEVANT
Our research →
Levetiracetam
Ours
FDA-approved antiepileptic drug, not a nootropic.
NOT-RELEVANT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Nooglutyl (Nooglutil)
Ours
Obscure Russian glutamate-axis nootropic — N-(5-hydroxynicotinoyl)-L-glutamic acid, developed at the Zakusov State Insti
NOT-RELEVANT P-P Emerging pill-oral-pharmaceutical
Our research →
Osteogenic Growth Peptide (OGP)
Ours
Endogenous regulatory peptide (histone H4 C-terminal fragment)
NOT-RELEVANT
Our research →
Quillivant XR
Ours
Tris Pharma's once-daily 12-hour extended-release liquid methylphenidate, FDA-approved 2012 for pediatric ADHD ages 6-17
NOT-RELEVANT P-P Emerging pill-oral-pharmaceutical
Our research →
Raloxifene
Ours
Second-generation benzothiophene SERM — bone agonist, breast/uterus antagonist — FDA-approved for postmenopausal osteopo
NOT-RELEVANT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Sertraline
Ours
SSRI (selective serotonin reuptake inhibitor)
NOT-RELEVANT
Our research →
T3 / Liothyronine
Ours
Active thyroid hormone.
NOT-RELEVANT P-P Emerging pill-oral-pharmaceutical
Our research →
Tamoxifen
Ours
First-generation triphenylethylene SERM and the original SERM — FDA-approved 1977 for invasive breast cancer, then DCIS
NOT-RELEVANT P-P Extensively Studied pill-oral-pharmaceutical
Our research →
Telmisartan
Ours
Long-half-life ARB (~24 hr, longest of the class) that also weakly agonizes PPARγ — making it the only ARB with a real m
NOT-RELEVANT P-P Emerging pill-oral-pharmaceutical
Our research →
Venlafaxine
Ours
SNRI (serotonin-norepinephrine reuptake inhibitor)
NOT-RELEVANT
Our research →
Agmatine Sulfate (redirect)
Ours
Endogenous polyamine
Our research →
Citicoline / CDP-Choline (redirect)
Ours
Cholinergic precursor
Our research →
Elvanse (redirect)
Ours
Amphetamine prodrug — long-acting d-amphetamine delivered via L-lysine peptide bond, cleaved by RBC aminopeptidase
Our research →
Ezetrol
Ours
REDIRECT — see ezetimibe.md
Our research →
Rhodiola rosea 3:1 Extract (redirect)
Ours
Adaptogen — Crassulaceae root extract; non-standardized 3:1 concentration ratio
Our research →
TRT
Theirs
Testosterone Replacement Therapy
P-P FDA Approved peptide-injectable
● Extended research — pep-pedia mirror ↗
No compounds match the current filters.